Gemzar, gemcitabine, is a chemotherapy drug for infusion.
Therapeutic indications are:
- Non Small Cell Lung Cancer: Gemcitabine is indicated for the palliative treatment of patients with locally advanced
or metastatic non-small cell lung cancer. - Breast cancer: Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant / neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.
- Pancreatic Cancer: Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.
- Bladder Cancer: Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage.
